T1	Condition 30 46	Type II diabetes
T2	Condition-Name 30 46	Type II diabetes
E1	Condition:T1 Name:T2
T3	Observation 52 67	Body mass index
T4	Observation-Name 52 67	Body mass index
E3	Observation:T3 Name:T4
A1	Observation-Type-Value T4 vital
T5	Observation 69 72	BMI
T6	Observation-Name 69 72	BMI
E5	Observation:T5 Name:T6 Eq-Comparison:E30
A2	Observation-Type-Value T6 vital
T9	Condition 610 618	diabetes
T10	Condition-Name 610 618	diabetes
E9	Condition:T9 Name:T10
T11	Condition 573 588	Type 1 diabetes
T12	Condition-Name 573 588	Type 1 diabetes
E11	Condition:T11 Name:T12
T13	Condition 686 698	ketoacidosis
T14	Condition-Name 686 698	ketoacidosis
E13	Condition:T13 Name:T14
T15	Condition 814 826	hypoglycemia
T16	Condition-Name 814 826	hypoglycemia
E15	Condition:T15 Name:T16 Severity:T91
T17	Condition 1220 1232	hypertension
T18	Condition-Name 1220 1232	hypertension
E17	Condition:T17 Name:T18
T19	Condition 652 660	diabetes
T20	Condition-Name 652 660	diabetes
E19	Condition:T19 Name:T20
T23	Procedure 994 1019	12-lead electrocardiogram
T24	Procedure-Name 994 1019	12-lead electrocardiogram
E23	Procedure:T23 Name:T24 Polarity:T62
T27	Eq-Operator 156 157	<
A3	Eq-Operator-Value T27 LT
T28	Eq-Operator 212 218	within
A4	Eq-Operator-Value T28 LTEQ
T29	Eq-Operator 494 500	within
A5	Eq-Operator-Value T29 LTEQ
T30	Eq-Operator 939 945	within
A6	Eq-Operator-Value T30 LTEQ
T31	Eq-Operator 1290 1296	within
A7	Eq-Operator-Value T31 LTEQ
T32	Eq-Operator 1368 1369	<
A8	Eq-Operator-Value T32 LT
T33	Eq-Temporal-Unit 753 759	months
A9	Eq-Temporal-Unit-Value T33 month
T34	Eq-Temporal-Unit 948 954	months
A10	Eq-Temporal-Unit-Value T34 month
T35	Eq-Temporal-Unit 1300 1304	days
A11	Eq-Temporal-Unit-Value T35 day
T36	Eq-Unit 83 92	kilograms
T37	Eq-Unit 111 113	kg
T38	Eq-Unit 161 170	kilograms
T39	Eq-Unit 172 174	kg
T40	Eq-Operator 79 80	-
A12	Eq-Operator-Value T40 BETWEEN
T41	Eq-Value 77 79	25
T42	Eq-Value 80 82	40
T43	Eq-Value 157 160	150
T46	Eq-Value 751 752	6
T47	Eq-Value 946 947	6
T51	Eq-Value 1297 1299	30
T52	Eq-Value 1369 1371	45
T54	Eq-Comparison 156 170	<150 kilograms
E26	Eq-Comparison:T54 Operator:T27 Unit:T38 Value:T43
T55	Eq-Comparison 939 954	within 6 months
E27	Eq-Comparison:T55 Operator:T30 Temporal-Unit:T34 Value:T47
T56	Eq-Comparison 1290 1304	within 30 days
E28	Eq-Comparison:T56 Operator:T31 Temporal-Unit:T35 Value:T51
T57	Eq-Comparison 1368 1418	<45 milliliters per minute per 1.73 meters squared
E29	Eq-Comparison:T57 Operator:T32 Value:T52 Unit:T25 Per:T26 Per2:T53
T58	Eq-Comparison 77 109	25-40 kilograms per square meter
E30	Eq-Comparison:T58 Operator:T40 Value:T41 Value2:T42 Unit:T36 Per:T7
R1	Abbrev-Of Arg1:E5 Arg2:E3	
T7	Eq-Unit 97 109	square meter
R2	Abbrev-Of Arg1:T37 Arg2:T36	
T8	Eq-Unit 114 116	m²
R3	Abbrev-Of Arg1:T8 Arg2:T7	
T63	Observation 141 152	body weight
E2	Observation:T63 Name:T64 Eq-Comparison:E26
T64	Observation-Name 141 152	body weight
A15	Observation-Type-Value T64 vital
R4	Abbrev-Of Arg1:T39 Arg2:T38	
T45	Observation 195 203	lab test
E4	Observation:T45 Name:T65 Eq-Comparison:E6
T65	Observation-Name 195 203	lab test
A16	Observation-Type-Value T65 lab
T66	Eq-Comparison 212 241	within normal reference range
E6	Eq-Comparison:T66 Unit:T67
T67	Eq-Unit 219 241	normal reference range
A17	Eq-Unit-Value T67 ref-range-normal
T68	Observation 412 427	serum magnesium
E7	Observation:T68 Name:T69 Eq-Comparison:E14
T69	Observation-Name 412 427	serum magnesium
A18	Observation-Type-Value T69 lab
T70	Observation 432 448	potassium levels
E8	Observation:T70 Name:T71 Eq-Comparison:E14
T71	Observation-Name 432 448	potassium levels
A19	Observation-Type-Value T71 lab
T72	Observation 461 482	lactate dehydrogenase
E10	Observation:T72 Name:T73 Eq-Comparison:E14
T73	Observation-Name 461 482	lactate dehydrogenase
A20	Observation-Type-Value T73 lab
T74	Observation 484 486	CK
E12	Observation:T74 Name:T75 Eq-Comparison:E14
T75	Observation-Name 484 486	CK
A21	Observation-Type-Value T75 lab
T76	Eq-Comparison 494 517	within the normal range
E14	Eq-Comparison:T76 Operator:T29 Unit:T77
T77	Eq-Unit 505 517	normal range
A22	Eq-Unit-Value T77 ref-range-normal
T78	And 428 431	and
E16	And:T78 Arg:E7 Arg2:E8
T79	And 450 460	along with
E18	And:T79 Arg:E8 Arg2:E10
T44	Study 521 530	screening
E20	Study:T44 
T80	Temporal-Connection 518 520	at
E22	Temporal-Connection:T80 Arg:E12 Arg2:E20
A23	Temporal-Connection-Type-Value E22 during
T83	Or 589 591	or
E33	Or:T83 Arg:E11 Arg2:E9
T81	Modifier 592 609	latent autoimmune
E24	Modifier:T81 Modifies:T10
T82	Modifier 619 628	in adults
E34	Modifier:T82 Modifies:T10
T84	Modifier 639 651	uncontrolled
E35	Modifier:T84 
R5	Abbrev-Of Arg1:E35 Arg2:E19	
T85	Condition 702 720	hyperosmolar state
E36	Condition:T85 Name:T86
T86	Condition-Name 702 720	hyperosmolar state
T87	Or 699 701	or
E37	Or:T87 Arg:E13 Arg2:E36
R6	Equivalent-To Arg1:E13 Arg2:E19	
T88	Encounter 731 746	hospitalization
E38	Encounter:T88 Type:T89 Duration:E31
T89	Encounter-Type 731 746	hospitalization
A24	Encounter-Type-Value T89 inpatient
T59	Eq-Comparison 751 759	6 months
E31	Eq-Comparison:T59 Value:T46 Temporal-Unit:T33
R7	Treatment-For Arg1:E38 Arg2:E36	
T60	Study 769 778	screening
E39	Study:T60 
T90	Temporal-Connection 760 768	prior to
E40	Temporal-Connection:T90 Arg:E31 Arg2:E39
A13	Temporal-Connection-Type-Value E40 before
T91	Severity 807 813	severe
A25	Severity-Value T91 severe
T92	Condition 857 872	neuroglycopenic
E41	Condition:T92 Name:T93
T93	Condition-Name 857 872	neuroglycopenic
T94	Assertion 873 881	symptoms
E42	Assertion:T94 Asserted:E41
A26	Assertion-Type-Value E42 possible
R8	Equivalent-To Arg1:E41 Arg2:E15	
T21	Observation 896 924	assistance of another person
E21	Observation:T21 Name:T22 Temporality:E27
T22	Observation-Name 896 924	assistance of another person
R9	Treatment-For Arg1:E21 Arg2:E41	
T48	Study 964 969	Visit
E32	Study:T48 
T61	Temporal-Connection 955 960	prior
E43	Temporal-Connection:T61 Arg:E27 Arg2:E32
A14	Temporal-Connection-Type-Value E43 before
T62	Polarity 985 993	abnormal
A27	Polarity-Value T62 abnormal
T49	Procedure 1021 1024	ECG
E44	Procedure:T49 Name:T95
T95	Procedure-Name 1021 1024	ECG
R10	Abbrev-Of Arg1:E44 Arg2:E23	
T96	Study 1029 1038	screening
E45	Study:T96 
T50	Study 535 538	Day
E46	Study:T50 
T97	And 531 534	and
E47	And:T97 Arg:E20 Arg2:E46
T98	Study 1046 1049	Day
E48	Study:T98 
T99	Or 1039 1045	and/or
E49	Or:T99 Arg:E45 Arg2:E48
T100	Temporal-Connection 1026 1028	at
E50	Temporal-Connection:T100 Arg:E44 Arg2:E45
A28	Temporal-Connection-Type-Value E50 during
T101	Study 1152 1157	study
E51	Study:T101 
T102	Risk 1109 1114	risks
E52	Risk:T102 Stability:T103
R11	Caused-By Arg1:E52 Arg2:E51	
T103	Stability 1095 1104	increases
A29	Stability-Value T103 change
R12	Caused-By Arg1:T103 Arg2:E44	
T104	Modifier 1202 1219	poorly controlled
E53	Modifier:T104 
R13	Abbrev-Of Arg1:E53 Arg2:E17	
T105	Study 1236 1245	screening
E54	Study:T105 
T106	Temporal-Connection 1233 1235	at
E55	Temporal-Connection:T106 Arg:E17 Arg2:E54
A30	Temporal-Connection-Type-Value E55 during
T107	Drug 1262 1289	antihypertensive medication
E56	Drug:T107 Name:T108 Stability:T109 Temporality:E28
T108	Drug-Name 1262 1289	antihypertensive medication
T109	Stability 1252 1258	change
A31	Stability-Value T109 change
T110	Or 1247 1249	or
E57	Or:T110 Arg:E54 Arg2:T109
T111	Study 1308 1317	screening
E58	Study:T111 
T112	Temporal-Connection 1305 1307	of
E59	Temporal-Connection:T112 Arg:E28 Arg2:E58
A32	Temporal-Connection-Type-Value E59 before
T114	Observation 1331 1367	estimated glomerular filtration rate
E61	Observation:T114 Name:T115
T115	Observation-Name 1331 1367	estimated glomerular filtration rate
A33	Observation-Type-Value T115 lab
T25	Eq-Unit 1372 1383	milliliters
T26	Eq-Temporal-Unit 1388 1394	minute
A34	Eq-Temporal-Unit-Value T26 minute
T53	Eq-Unit 1399 1418	1.73 meters squared
T116	Eq-Unit 1441 1443	mL
R14	Abbrev-Of Arg1:T116 Arg2:T25	
T117	Eq-Temporal-Unit 1444 1447	min
A35	Eq-Temporal-Unit-Value T117 minute
T118	Eq-Unit 1448 1455	1.73 m²
R15	Abbrev-Of Arg1:T118 Arg2:T53	
